Pre-analytic variability in cardiovascular biomarker testing

Roberto Cemin1, Massimo Daves1

  • 11 Department of Cardiology, San Maurizio Regional Hospital of Bolzano, Bolzano, Italy ; 2 Clinical Pathology Laboratory, Hospital of Merano, Merano, Italy.

Insights

Pre-analytic variability significantly impacts cardiovascular biomarker testing quality. Understanding factors affecting cardiac troponins and natriuretic peptides is crucial for accurate clinical cardiology results and avoiding errors.

Area of Science:

  • Laboratory Medicine
  • Clinical Cardiology
  • Biomarker Analysis

Background:

  • Laboratory medicine plays an increasingly vital role in clinical cardiology.
  • Numerous cardiovascular biomarkers have been introduced, enhancing diagnostic capabilities.
  • Pre-analytic variability is a major, often underestimated, source of laboratory errors.

Purpose of the Study:

  • To review the determinants of pre-analytic variability in cardiovascular biomarker testing.
  • To highlight the significance of pre-analytic factors for common biomarkers.
  • To improve the quality of laboratory results in cardiology.

Main Methods:

  • Literature review focusing on pre-analytic variability.
  • Analysis of factors affecting cardiovascular biomarker testing.
  • Emphasis on cardiac troponins and natriuretic peptides.

Main Results:

  • Pre-analytic variability is a substantial source of bias in laboratory testing.
  • Specific determinants of variability for cardiac troponins and natriuretic peptides are identified.
  • Awareness of these factors is essential for physicians.

Conclusions:

  • Addressing pre-analytic variability is critical for reliable cardiovascular biomarker results.
  • Understanding pre-analytic factors enhances the accuracy of clinical cardiology.
  • Minimizing laboratory errors requires attention to pre-analytic sample handling.

Related Concept Videos

Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
636
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
742
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.8K
Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
11.4K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
280